9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Cooley-Led Biotech Nixes IPO, Scores $142M Funding Round

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Cooley-Led Biotech Nixes IPO, Scores $142M Funding Round

Cooley-Led Biotech Nixes IPO, Scores $142M Funding Round

Law360 (April 23, 2019, 5:45 PM EDT) — Cancer-focused biotechnology firm Poseida Therapeutics Inc. has decided to put plans for an initial public offering on hold, with the Cooley LLP-guided company instead picking up $142 million in a funding…

Call Now ButtonCall For Free Consultation